Human pathology

Hum Pathol · ISSN (e) 1532-8392 · 54 papers in corpus
article 2026
doi:10.1016/j.humpath.2026.106171 ·PMID:42208772

Endometriosis is defined by the presence of endometrial glands and stroma outside the uterine cavity. Although it typically presents within the pelvis, extragenital manifestations are well documented with gastrointestinal (GI) involvement b…

other 2025
doi:10.1016/j.humpath.2025.105784 ·PMID:40319947

Endometrial stromal sarcoma (ESS) is a mesenchymal tumor known for infiltrative growth and lymphovascular invasion. Most examples arise in the endometrium, but some occur in the abdominal cavity without a primary uterine lesion, likely orig…

article 2025
doi:10.1016/j.humpath.2025.105875 ·PMID:40706757

OBJECTIVE: - Atypical endometriosis (AE) is considered a potential precursor of endometriosis-associated ovarian carcinoma (EAOC). Despite this, AE identification currently lacks established clinical implications and is not routinely incorp…

other 2021
doi:10.1016/j.humpath.2020.11.013 ·PMID:33259844

Adenomyoma of the uterus is a biphasic nodular lesion composed of a mesenchymal component with smooth muscle differentiation and a glandular epithelium. The neoplastic nature of uterine adenomyomas has been controversial because some are co…

other 2021
doi:10.1016/j.humpath.2021.04.005 ·PMID:33887302

Antibodies targeting uroplakin II (UPII) are highly specific for urothelial cells and are frequently used to determine if a primary bladder lesion or a metastatic lesion originates from the urothelium. However, to date, no studies have test…

article 2021
doi:10.1016/j.humpath.2021.11.009 ·PMID:34856302

Intravenous leiomyomatosis (IVL) is a quasi-malignant smooth muscle tumor involving lymphatic and venous spaces of the myometrium. Rare cases of IVL with admixed endometrial glands and stroma have been described, termed intravascular adenom…

other 2020
doi:10.1016/j.humpath.2020.01.002 ·PMID:32017945

The expression frequency and distribution of glypican-3 (GPC3) was retrospectively assessed by immunohistochemistry in 316 accurately phenotyped ovarian clear cell carcinoma (OCCC) specimens from Canadian patients. The study aimed to evalua…

article 2019
doi:10.1016/j.humpath.2019.04.001 ·PMID:31022415

We focused on specific molecular events during the development of endometriosis-associated ovarian endometrioid carcinoma (OEmCa) and ovarian clear cell carcinoma (OCCCa). Alterations in β-catenin (encoded by CTNNB1) and microsatellite inst…

article 2019
doi:10.1016/j.humpath.2019.08.004 ·PMID:31430494

Appendiceal endometriosis, endosalpingiosis, and decidual lesions have received little attention in the pathology literature, meaning their clinicopathologic features remain unclear. We identified 72 cases of appendiceal gynecologic prolife…

article 2018
doi:10.1016/j.humpath.2018.10.028 ·PMID:30447298

Ovarian clear cell and endometrioid carcinomas (type I) are thought to develop from endometriosis. ARID1A loss of expression is known to be related to the promotion of the endometriosis carcinogenesis. Despite the diverse origins and progno…

review 2018
doi:10.1016/j.humpath.2018.06.018 ·PMID:29944973

Based on histopathology and molecular genetics, ovarian carcinomas are divided into five main types: high-grade serous (70%), endometrioid (10%), clear cell (10%), mucinous (3%), and low-grade serous (<5%) carcinomas. These tumors, which ac…

other 2018
doi:10.1016/j.humpath.2018.08.001 ·PMID:30120969

A potential role for viral infections has been implicated in inflammatory bowel disease (IBD) unresponsive to medical treatment. It is well known that Epstein-Barr virus (EBV) infection can elicit a brisk mononuclear response in the gastroi…

article 2017
doi:10.1016/j.humpath.2017.04.008 ·PMID:28438620

Recent studies demonstrated that protease-activated receptor-2 (PAR-2) correlates with tumor progression in various tissues. On the other hand, oxidative stress arising from endometriosis has been considered a cause of carcinogenesis in ova…

article 2017
doi:10.1016/j.humpath.2017.08.013 ·PMID:28843713

When hysterectomy is performed for chronic pelvic pain, routine pathology examination often provides no explanation. However, analysis of small uterine nerves using immunostains may help to address this deficiency. Small uterine nerves tend…

2016
doi:10.1016/j.humpath.2016.03.006 ·PMID:27068525

Inflammatory cytokines, like tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), are elevated in ovarian cancer. Differences in cytokine expression by histologic subytpe or ovarian cancer risk factors can provide useful insight in…

2015
doi:10.1016/j.humpath.2015.02.015 ·PMID:25841305

Triple negative (TN) (estrogen receptor [ER], progesterone receptor [PR] and HER2-) are highly aggressive, rapidly growing, hormone-unresponsive tumors diagnosed at later stage that affect younger women with shorter overall survival. Most T…

other 2014
doi:10.1016/j.humpath.2013.11.005 ·PMID:24491354

Endometrial cysts within the liver are rare but can present as diagnostic challenges on small biopsies or frozen sections and may mimic mucinous cystic neoplasms (MCN) of the liver. Five cases of endometrial cysts and 6 cases of MCNs within…

review 2013
doi:10.1016/j.humpath.2013.04.009 ·PMID:23845467

This review article describes the main features of epithelial-to-mesenchymal transition (EMT) and its possible role in understanding myometrial invasion in endometrial carcinoma (EC), as well as the development of malignant mixed Müllerian …

article 2012
doi:10.1016/j.humpath.2011.09.013 ·PMID:22221703

The pathogenesis of endometriosis is unclear, and several genetic, endocrine, immune, and environmental agents have been evaluated with no putative causative factors identified. Here, we show somatic genetic alterations involving HMGA1 (6p2…

article 2012
doi:10.1016/j.humpath.2012.02.005 ·PMID:22626277

Inflammation in the ovary, including ovulation and pelvic inflammatory disease, has been proposed to play a role in the pathogenesis of ovarian cancer. Endometriotic lesions trigger a local inflammatory reaction and have been reported to be…

article 2012
doi:10.1016/j.humpath.2011.10.009 ·PMID:22305241

The association between ovarian endometrioid adenocarcinoma and endometriosis is well established. However, not all endometrioid adenocarcinomas are directly related to endometriosis, and it has been suggested that there may be clinicopatho…

article 2011
doi:10.1016/j.humpath.2011.06.020 ·PMID:21944080

It is currently thought that most clear cell and endometrioid carcinomas arise from ovarian endometriosis. We recently suggested that, besides their origin in the ovary, reduction of CDC42 messenger RNA (a member of the RHO GTPase family) m…

article 2011
doi:10.1016/j.humpath.2010.10.015 ·PMID:21777942

Intravenous leiomyomatosis is a rare variant of leiomyoma that could result in death. Early and accurate diagnosis and appropriate treatment strategies play a dominant role in good prognosis. Eighteen cases of Intravenous leiomyomatosis , a…

review 2011
doi:10.1016/j.humpath.2011.03.003 ·PMID:21683865

Recent morphologic, immunohistochemical, and molecular genetic studies have led to the development of a new paradigm for the pathogenesis and origin of epithelial ovarian cancer based on a dualistic model of carcinogenesis that divides epit…

other 2010
doi:10.1016/j.humpath.2009.10.011 ·PMID:20060152

Although clear cell adenocarcinoma have been described focally mimicking nephrogenic adenoma, we have identified a subset of clear cell adenocarcinoma that diffusely resembles nephrogenic adenoma (nephrogenic adenoma-like clear cell adenoca…